Roy Vagelos Net Worth & Insider Trades

Roy Vagelos - Director, Theravance Inc

As of December 23, 2009

What is Roy Vagelos's Net Worth?

The current estimated net worth of Theravance Inc's Director, Roy Vagelos, is estimated to be about $468.22M . Roy Vagelos owns about 513,006 units of Theravance Inc common stock. In the last 3 years at Theravance Inc, Roy Vagelos has sold an estimated value of $0 worth.

What is Roy Vagelos's Past Insider Trading?

Roy Vagelos's largest purchase order was 31,700 units , worth over $331.34K on March 17, 2008. In total, Roy Vagelos has made about 7 transactions over 3 years of their time at Theravance Inc. Roy Vagelos usually trades in April, with the busiest year in 2008. The most recent transaction was a purchase order of 17,300 units , worth over $177.36K on March 17, 2008.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What are Theravance Inc's Past Insider Trades?

Theravance Inc's most recent insider trade came on December 1, 2022 by Bradford Dahms who bought 1,502 units worth $10K . In the last 18 years, insiders at Theravance Inc have sold an estimated value of $79.05M and bought an estimated value of $606.09M worth of shares. Insider trading is most common in April, with the busiest year in 2014. The most active traders at the company are Michael W Aguiar, President & CEO,  Bradford J Shafer, Sr VP,  and Mathai Mammen, SVP .

Theseus Pharmaceuticals, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1